ACADIA Pharmaceuticals Inc Sustainability Reports
ACADIA Pharmaceuticals Inc. focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company provides targeted treatments for conditions including Parkinson's disease psychosis and Rett syndrome.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900O3044NO0PEA039
FIGI: BBG001SB06N3
13 reports from 2013 to 2025
